Richard Collin

ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada.

GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.

Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada.

Part of Clean Cells SAS, Biodextris, Inc. is a contract research organization based in Laval, Canada. The Canadian company provides analytical, process development, and CMC consulting services for vaccines and biologics in the clinical stages of development. Biodextris' expertise, facilities, and quality systems support clients in navigating a path from R&D to early-phase clinical trials. The company was founded in 2015 by Joseph Zimmermann, who has been the CEO since then. On May 05, 2021, Biodextris was acquired by Clean Cells SAS.